AlphaQuest’s Aura Biosciences AURA Stock Holding History

AlphaQuest’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,511	Closed	-$136K	–	2027
2024 Q4	$136K	Buy	+16,511	New	+$155K	0.02%	1008

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AlphaQuest's AURA Position: Q1 2025 in Review

AlphaQuest sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 16,511 shares — an estimated $136K sold.

AlphaQuest first reported a position in AURA in Q4 2024 and held it in 1 quarter. The position peaked at $136K in Q4 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

AlphaQuest reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
AlphaQuest sold 16,511 Aura Biosciences shares in Q1 2025, an estimated $136K.
AlphaQuest first reported a position in Aura Biosciences in Q4 2024 and held it in 1 quarter.
AlphaQuest's Aura Biosciences position peaked at $136K in Q4 2024.
94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on AlphaQuest's 13F filing for Q1 2025, filed 14 May 2025.